Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Gene | PIK3CA |
| Variant | E453V |
| Impact List | missense |
| Protein Effect | unknown |
| Gene Variant Descriptions | PIK3CA E453V lies within the C2 PI3K-type domain of the Pik3ca protein (UniProt.org). E453V has been identified in sequencing studies (PMID: 27135926), but has not been biochemically characterized and therefore, its effect on Pik3ca protein function is unknown (PubMed, Feb 2026). |
| Associated Drug Resistance | |
| Category Variants Paths |
PIK3CA mutant PIK3CA exon8 PIK3CA E453V |
| Transcript | NM_006218.4 |
| gDNA | chr3:g.179210292A>T |
| cDNA | c.1358A>T |
| Protein | p.E453V |
| Source Database | RefSeq |
| Genome Build | GRCh38/hg38 |
| Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
|---|---|---|---|---|---|
| XM_006713658.5 | chr3:g.179210292A>T | c.1358A>T | p.E453V | RefSeq | GRCh38/hg38 |
| NM_006218.4 | chr3:g.179210292A>T | c.1358A>T | p.E453V | RefSeq | GRCh38/hg38 |
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT07522697 | Phase II | Inavolisib | Inavolisib for PIK3CA Mutated Advanced Endometrial Cancer: MITO END-4 (MITO END-4) | Not yet recruiting | ITA | 0 |